Company / Cost of Revenue
AtriCure, Inc. Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$133.7M
FY2025
5-year range
$68.5M / $133.7M
FY2021-FY2025
Trend
+13.6%
vs FY2024
Sector context
#80 of 107
Health Care
What the data says
AtriCure, Inc.'s cost of revenue of $134M is lower than 75% of companies in the Health Care sector (FY2025). Cost of Revenue has increased for 6 consecutive years, from $635,000 in FY2019 to $134M in FY2025.
Based on SEC 10-K filings.
$134M in FY2025 with a 5-year CAGR of +189.7%.
Increased from $99M to $134M over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +16.6%
- 5-Year CAGR
- +189.7%
- 10-Year CAGR
- -
Sector benchmark
Top 25% in Health CareTop 25% of 107This company $133.7M Sector average $11.8B
▼
-98.9% below sector average
Key checks
Key Insights
- AtriCure, Inc.'s cost of revenue has grown for 6 consecutive years.
- 5-year CAGR of +189.7%, indicating consistent growth.
- In FY2025, cost of revenue increased 13.6% year-over-year.
- Ranks #80 out of 107 companies in the Health Care sector.
Company context
Key Data Points
- Negative profit margin: -9.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $133.7M | +13.6% |
| FY2024 | $117.8M | +19.1% |
| FY2023 | $98.9M | +17.1% |
| FY2022 | $84.4M | +23.3% |
| FY2021 | $68.5M | +10353.3% |
| FY2020 | $655.0K | +3.1% |
| FY2019 | $635.0K | -19.1% |
| FY2018 | $785.0K | -12.8% |
| FY2017 | $900.0K | +44.0% |
| FY2016 | $625.0K | -98.3% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026